Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03GAI
|
||||
| Former ID |
DIB000108
|
||||
| Drug Name |
IR-103
|
||||
| Synonyms |
HIV vaccine + Amplivax, IRC; HIV vaccine + Amplivax, Immune Response Corp; HIV vaccine + HYB-2055, IRC; HIV vaccine + HYB-2055, Immune Response Corp; Vaccine (HIV) + Amplivax, IRC; Vaccine (HIV) + Amplivax, Immune Response Corp; Vaccine (HIV) + HYB-2055, IRC; Vaccine (HIV) + HYB-2055, Immune Response Corp
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Discontinued in Phase 3 | [547777] | ||
| Company |
Immune Response BioPharma Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Toll-like receptor 9 | Target Info | [543477] | ||
| NetPath Pathway | BCR Signaling Pathway | ||||
| PANTHER Pathway | Toll receptor signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.